Biology and Evolution of Microorganisms

The Biology and Evolution of Microorganisms Group, whose head is Dr. Rafael Cantón and which is made up of nine other principal investigators as well as numerous pre- and post-doctoral researchers, technicians and other healthcare personnel, has participated in the last 5 years in 17 national and international research projects and in 15 contracts with pharmaceutical companies or companies dedicated to in vitro diagnostics. During this period of time this work has resulted in more than 190 publications in national and international journals with a high impact index and more than 11 doctoral theses. Likewise, more than 400 communications have been presented at numerous national and international congresses. And all this always seeking the highest excellence in the fields of population biology, antibiotic resistance, respiratory infection, microbiota, metagenomics and HIV.

2024 Activity indicators

9 european competitive projects: IMI, H2020, HE, ERC-STG, EU4HEALTH, JPIAMR
13 national public competitive projects: ISCIII, CAM, MICIIN
13 private projects led
5 clinical studies
15 HR competitive contracts
99 publications
IF: 519.90
Q1 publications: 53 (54%)
D1 publications: 24 (24%)
2 thesis
7 awards
Project evaluators: 8 group members
Members of editorial committees: 6 PI
1 Spanish trademark registration and software registration (M4263261 and 2404247750786-2ETRXK) of EPIMOLBIO and a European patent application with the title "European priority application aptamers against HIV proteins" (EP24383092.4).
2 clinical guidelines, 1 consensus document, 1 procedure, 1 European agenda
9 visitors hosted and 13 months of stay:
- MIKROBIOMIK (Spain)
- Hospital Reina Sofia (Spain)
- University of Veterinary Sciences BRNO. (Czech Rep.)
- MCI Management Center Innsbruck (Austria)
- Harvard University School of Medicine. Boston (USA)
- Max Planck Institute for Evolutionary Biology. Piön (Germany)
- Emory University. Atlanta (USA)
- Colombian Center for Genomics and Bioinformatics of Extreme Environments. Bogotá (Colombia)
- Hospital Virgen del Rocío. Seville (Spain)
11 months stay in 3 foreign centers:
- Yale University (USA)
- Alexander von Humboldt Institute of Tropical Medicine.
  Peruvian University Cayetano Heredia. San Martín de Porrez (Peru)
- Wellcome Wolfson Institute for Experimental Medicine (Queens University Belfast). Belfast (United Kingdom)

Milestones

Attraction of resources in competitive calls for international (ERADIAMR AC23_2/00047) and national projectsfrom ISCIII (PI24/01898, PI24/01449, FOR23/00046 FORTALECE), MICINN (CPP2023-010453 Ministry of Science, Innovation and Universities), local (UAH- IRYCIS23/11_COMTI), including HR (1 Rio Hortega CM23/00037, Predoctoral CAM PIPF-2023/SAL-GL-30595, Research Assistant CAM PEJ-2024-AI/SAL-GL-31755 for attracting research talent "César Nombela" of the CAM) and agreements with pharmaceutical, biotechnology and diagnostic companies (QBD, GILEAD) and Foundations (Family Alonso, Eugenio Rodríguez Pascual Foundation).
Recognition of its researchers: 1) Margarita Salas Award of the CAM to those under 40 years of age, 2) National Award of Margarita Salas Research, area of biology, 3) Amadeo Foz Award of the Spanish Society of Infectious Diseases and Clinical Microbiology and 4) Inclusion of 3 of its researchers in the world list "top 2% scientist" according to the University of Stanford.
Appointment as Head of Area 2 of the IRYCIS (Microbiology, Immunology and Infection) of one of its Principal Investigators, Dr. Rosa del Campo.
Start of activities as a European Union Reference Laboratory (EURL) in in vitro diagnostic devices for class D (EURL-IVD.1: Harmonization process of European Reference Laboratories for in vitro diagnosis).
International cooperation in Africa and Latin America. Participation in HIV/AIDS counseling programs, project on HIV research in children and training of health professionals in the area of diagnosis.

Bibliometrics

	Articles	Accum. IF	Mean IF	Articles Q1 or Q2	% in Q1 or Q2	Articles D1	% in D1
2020	104	413.83	4.36	72	69	19	18
2021	108	686.36	6.60	80	74	19	18
2022	114	856.67	8.16	85	75	15	13
2023	92	699.12	8.32	67	73	19	21
2024	99	519.90	6.05	71	72	24	24
	517	3175.88	6.70	375	73	96	19

* Only original articles, editorial material, guidelines and reviews.

Networks and alliances

PRECICOLON-CM. Hacia la medicina de precisión en cáncer de colon: biomarcadores, microambiente tumoral y microbiota
CHAFEA-Consumers, Health, Agriculture and Food Executive Agency
Red de secuenciación de SARS-CoV-2